A biomedical sciences professor and her team have developed a method to program T-cells to target and eliminate senescent cells, which are linked to aging and age-related diseases. In lab mice, this treatment resulted in rejuvenation for older mice and slower aging for younger ones, with long-lasting effects. If successful in humans, this therapy could potentially provide lifelong anti-aging benefits and may represent a significant breakthrough in medicine.
Postdoctoral positions in the pharmaceutical industry are often overlooked by graduates in the biomedical sciences, despite the fact that nearly half of science and engineering PhDs end up employed by industry. The lack of awareness about industry postdocs has led to misconceptions that these positions are less prestigious and money-motivated. However, industry postdocs offer several benefits, including exposure to the latest technologies, higher salaries, and the opportunity to work on translational research that can impact patients' lives. Companies like Novartis and Genentech provide postdoc programs that combine fundamental science with drug discovery projects. While proprietary restrictions may limit the ability to publish work, industry postdocs offer valuable networking opportunities and access to cutting-edge research. Efforts are being made to increase awareness and establish long-term relationships between academic institutes and pharmaceutical companies to promote industry postdoc opportunities.
